NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer. These proteins are implicated in epidermal squamous cell carcinoma in mice, however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours, blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma. Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer, it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon cotransfection with the human TERT gene, defined sets of oncogenes, specifically activated H-RAS, SV40 large T antigen and SV40 small t antigen, resulted in the efficient malignant transformation of human fibroblasts (96).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [96]
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Cutaneous Squamous-Cell Carcinoma
Alam, M., & Ratner, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441306 · Cited by 1,305
Nonmelanoma skin cancer in the United States: Incidence
Miller, D. L., & Weinstock, M. A. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81509-5 · Cited by 1,098 · cited 1×
“jpg" NDATA ITEM> ]> The nuclear factor NF-κB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cance”
BackgroundHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878 · cited 1×
“Ectopic subcutaneous tumour formation in mice often requires administration of matrigel or fibroblast-derived matri”
BackgroundBlocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831 · cited 1×
“Because therapeutics inhibiting Ras and NF-κB pathways are being developed to treat human cance”
Background
Cited by
Items 201–300 of 540
Pan, Y., Huang, J., Xing, R., Yin, X., Cui, J., Li, W., Yu, J. Q., & Lu, Y. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-173 · Cited by 63
“Activation of NF-κB is resulted from proteasome-mediated degradation of IκB-α by phosphorylation of the inhibitor (p-IκB-α), which suggests that NF-κB pathway is a potential target for individual therapy [20–23].”
Cruz‐Monserrate, Z., Qiu, S., Evers, B. M., & O’Connor, K. L. (2007) · Modern Pathology · doi:10.1038/modpathol.3800782 · Cited by 71
Ras and Raf pathways in epidermis development and carcinogenesis
Kern, F., Niault, T., & Baccarini, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606009 · Cited by 69
Crosstalk between PARP-1 and NF-κB modulates the promotion of skin neoplasia
Martín‐Oliva, D., O’Valle, F., Muñoz‐Gámez, J. A., Valenzuela, M. T., Núñez, M. I., Aguilar, M., de Almodóvar, J. M. R., del Moral, R. G., & Oliver, F. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207696 · Cited by 62
“Nonetheless, this concept has been challenged by the Khavari’s group in a recent publication where they find that blockade of NF-kB by IkBa circumvents restraints on human epidermal cells growth promotion induced by oncogenic Ras (Dajee et al., 2003).”
BackgroundType II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
Fisher, M. L., Adhikary, G., Xu, W., Kerr, C. L., Keillor, J. W., & Eckert, R. L. (2015) · Oncotarget · doi:10.18632/oncotarget.3890 · Cited by 61
Hamill, K. J., Hopkinson, S. B., Debiase, P., & Jones, J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0051 · Cited by 61
“In addition to its well established role in adhesion, ␣64 integrin has been reported to regulate cell migration and tumor invasion (Rabinovitz and Mercurio, 1996, 1997; Mercurio et al., 2001; Dajee et al., 2003; Nikolopoulos et al., 2004; Nikolopoulos et al., 2005; Sehgal et al., 2006).”
Non-melanoma skin cancer in mouse and man
Schwarz, M., Münzel, P., & Braeuning, A. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0998-9 · Cited by 61
“Experiments with human keratinocyte xenografts transfected with an activated version of Ha-ras demonstrated Ras-induced growth arrest which could be overcome by the inhibition of NF-jB signaling, which by itself enhanced apoptosis in keratinocytes (Dajee et al. 2003).”
BackgroundHasegawa, M., Furuya, M., Kasuya, Y., Nishiyama, M., Sugiura, T., Nikaido, T., Momota, Y., Ichinose, M., & Kimura, S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700657 · Cited by 60
Epidermal p65/NF‐κB signalling is essential for skin carcinogenesis
KIM, C. S., & Pasparakis, M. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303541 · Cited by 60
“In addition, inhibition of NF-j B signalling in human keratinocytes promoted RAS-mediated transformation in a xenograft model (Dajee et al , 2003).”
Duperret, E. K., Dahal, A., & Ridky, T. W. (2015) · Journal of Cell Science · doi:10.1242/jcs.175539 · Cited by 62
“Additionally, ablation or inhibition of integrin β1 (also known as ITGB1) or integrin α6β4 blocks tumor formation in mouse and human skin (Dajee et al., 2003; Reuter et al., 2009).”
BackgroundPourreyron, C., Cox, G. S., Mao, X., Volz, A., Baksh, N., Wong, T., Fassihi, H., Arita, K., O’Toole, E. A., Ocampo‐Candiani, J., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700878 · Cited by 60
“molecular events downstream of the Ras-driven oncogenesis (described by Dajee et al. (2003) and Ortiz-Urda et al.”
BackgroundLowe, J. M., Cha, H., Yang, Q., & Fornace, A. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034579 · Cited by 61
Chromatin-Bound IκBα Regulates a Subset of Polycomb Target Genes in Differentiation and Cancer
Mulero, M. C., Ferrés-Marcó, D., Islam, A. B. M. M. K., Margalef, P., Pecoraro, M., Toll, A., Drechsel, N. J. D., Charneco, C., Davis, S. M., Bellora, N., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.003 · Cited by 69
“…which is consistent with the tumorigenic phenotype of mice expressing the chromatin binding-defective IkBa super-repressor mutant in the skin (Dajee et al., 2003; van Hogerlinden et al., Cancer Cell 24, 1–16, August 12, 2013 ª2013 Elsevier Inc. 11 (legend continued on next page) IkBa Is a…”
BackgroundAberrant NF-κB Activity in HaCaT Cells Alters their Response to UVB Signaling
Lewis, D. A., Hengeltraub, S. F., Gao, F. C., Leivant, M. A., & Spandau, D. F. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700333 · Cited by 59
Sayama, K., Hanakawa, Y., Nagai, H., Shirakata, Y., Dai, X., Hirakawa, S., Tokumaru, S., Tohyama, M., Yang, L., Sato, S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601065200 · Cited by 59
Kondapalli, L., Soltani, K., & Lacouture, M. E. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.02.011 · Cited by 59
Inhibitor of κB Kinase Beta Regulates Gastric Carcinogenesis via Interleukin-1α Expression
Sakamoto, K., Hikiba, Y., Nakagawa, H., Hayakawa, Y., Yanai, A., Akanuma, M., Ogura, K., Hirata, Y., Kaestner, K. H., Omata, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.047 · Cited by 60
The Two-Faced NF-κB in the Skin
Sur, I., Ulvmar, M. H., & Toftgård, R. (2008) · International Reviews of Immunology · doi:10.1080/08830180802130319 · Cited by 65
Ni, H., Dydensborg, A. B., Herring, E., Basora, N., Gagné, D., Vachon, P. H., & Beaulieu, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208848 · Cited by 64
“…when tumor formation by human epidermal grafts in immunodeficient mice was found to be dependent upon the presence of the integrin b4 subunit (Dajee et al., 2003), while another recent study demonstrated the importance for the C-terminal tail (beyond aa 1355) of b4 for intracellular…”
BackgroundCDK4 regulation by TNFR1 and JNK is required for NF-κB–mediated epidermal growth control
Zhang, J. Y., Tao, S., Kimmel, R., & Khavari, P. A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411060 · Cited by 61
Self-citationTRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation
Piciu, F., Balaș, M., Badea, M. A., & Cucu, D. (2023) · Antioxidants · doi:10.3390/antiox12071327 · Cited by 61
“Additionally, in human epidermal cells, both NF-κB and oncogenic Ras trigger cell-cycle arrest [95].”
BackgroundRen, Q., Kari, C., Quadros, M. R. D., Burd, R., McCue, P., Dicker, A. P., & Rodeck, U. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4158 · Cited by 53
Pathways involved in sunburn cell formation: deregulation in skin cancer
Claerhout, S., Laethem, A. V., Agostinis, P., & Garmyn, M. (2005) · Photochemical & Photobiological Sciences · doi:10.1039/b504970a · Cited by 64
The Met Receptor and α6β4 Integrin Can Function Independently to Promote Carcinoma Invasion
Chung, J., Yoon, S.-O., Lipscomb, E. A., & Mercurio, A. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403809200 · Cited by 56
Raymond, K., Kreft, M., Song, J., Janssen, H., & Sonnenberg, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0720 · Cited by 62
Rule-Based Cell Systems Model of Aging using Feedback Loop Motifs Mediated by Stress Responses
Kriete, A., Bosl, W. J., & Booker, G. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000820 · Cited by 53
“However, the predicted increase in oxidative stress and related damage will not increase lifespan according to our simulation, consistent with premature aging observed in NFkB p50 knockout mice [94], and the change in redox state may further account for an observed predisposition of the epidermis to neoplasias in NF-k…”
BackgroundHiroi, M., & Ohmori, Y. (2003) · Biochemical Journal · doi:10.1042/bj20030842 · Cited by 61
Alameda, J. P., Moreno-Maldonado, R., Navarro, M., Bravo, A., Ramírez, Á., Page, A., Jorcano, J. L., Fernández‐Aceñero, M. J., & Casanova, M. L. (2010) · Oncogene · doi:10.1038/onc.2010.378 · Cited by 63
The c-Jun NH2-Terminal Kinase 2 Plays a Dominant Role in Human Epidermal Neoplasia
Ke, H., Harris, R., Coloff, J. L., Jin, J. Y., Leshin, B., de Marval, P. L. M., Tao, S., Rathmell, J. C., Hall, R. P., & Zhang, J. Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2923 · Cited by 59
Self-citationKing, K. E., Ponnamperuma, R. M., Allen, C. T., Lü, H., Duggal, P., Chen, Z., Waes, C. V., & Weinberg, W. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6123 · Cited by 57
“During the development and progression of SCC, the NF-nB1-Rel-A (p50/p65) heterodimer has been implicated in promotion or repression of the malignant phenotype dependent on the context (22, 23 ).”
BackgroundmiR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3
Zhou, Y., Dang, J., Chang, K.-Y., Yau, E., Aza-Blanc, P., Moscat, J., & Rana, T. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2936 · Cited by 54
“In addition, human squamous cell carcinoma induced by HRAS and IkBa can be inhibited by blocking antibodies against laminin 332 or b4 integrins (34).”
BackgroundInflammation and cancer: friend or foe?
Smith, A. D. T., Córdoba-Hernandez, S., Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., & Rodríguez-García, J. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385479 · Cited by 61
Doma, E., Rupp, C., & Baccarini, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019361 · Cited by 61
Targeting CREB Pathway Suppresses Small Cell Lung Cancer
Xia, Y., Zhan, C., Feng, M., Leblanc, M., Ke, E., Yeddula, N., & Verma, I. M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0576 · Cited by 63
Systemic Targeting Inhibitor of κB Kinase Inhibits Melanoma Tumor Growth
Yang, J., Pan, W.-H., Clawson, G. A., & Richmond, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3547 · Cited by 54
Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. B. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.001 · Cited by 58
Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo
Liu, M., Ju, X., Willmarth, N. E., Casimiro, M. C., Ojeifo, J. O., Sakamaki, T., Katiyar, S., Jiao, X., Popov, V. M., Yu, Z., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080706 · Cited by 57
Patel, G. K., Yee, C., Terunuma, A., Telford, W. G., Voong, N., Yuspa, S. H., & Vogel, J. C. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.317 · Cited by 54
“Dajee et al., 2003).”
NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
Colomer, C., Marruecos, L., Vert, A., Bigas, A., & Espinosa, L. (2017) · Biomedicines · doi:10.3390/biomedicines5020026 · Cited by 52
Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia
Scholl, F. A., Dumesic, P. A., Barragan, D. I., Harada, K., Charron, J., & Khavari, P. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1963 · Cited by 53
“This finding is more pronounced in epithelial squamous cell carcinomas (SCC), the majority of which exhibit Ras GTPase activation and MAPK cascade hyperactivation (3, 4).”
BackgroundSelf-citationKuonen, F., Huskey, N. E., Shankar, G., Jaju, P. D., Whitson, R. J., Rieger, K. E., Atwood, S. X., Sarin, K. Y., & Oro, A. E. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.035 · Cited by 52
“…activation, appears permissive for the dominant oncogenic Ras/MAPK pathway, which is involved in both skin differentiation (Dajee et al., 2002; Dlugosz et al., 1994; Lin and Lowe, 2001; Mainiero et al., 1997) and SCC carcinogenesis (Dajee et al., 2003; To et al., 2005; Woodworth et al., 2004).”
BackgroundIn vivo gene manipulation reveals the impact of stress‐responsive MAPK pathways on tumor progression
Kamiyama, M., Naguro, I., & Ichijo, H. (2015) · Cancer Science · doi:10.1111/cas.12676 · Cited by 53
Genetic susceptibility of cervical cancer
Chen, X., Jiang, J., Shen, H., & Hu, Z. (2011) · Journal of Biomedical Research · doi:10.1016/s1674-8301(11)60020-1 · Cited by 50
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
Kabacaoğlu, D., Ruess, D. A., Ai, J., & Algül, H. (2019) · Cancers · doi:10.3390/cancers11070937 · Cited by 56
ASPP2 suppresses squamous cell carcinoma via RelA/p65–mediated repression of p63
Tordella, L., Koch, S., Salter, V., Pagotto, A., Doondeea, J. B., Feller, S. M., Ratnayaka, I., Zhong, S., Goldin, R. D., Lozano, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309362110 · Cited by 53
McTavish, N., Copeland, L., Saville, M. K., Perkins, N. D., & Spruce, B. A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402172 · Cited by 50
Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders
Ko, M. S., & Marinkovich, M. P. (2009) · Dermatologic Clinics · doi:10.1016/j.det.2009.10.001 · Cited by 49
Self-citationRolfs, F., Huber, M., Kuehne, A., Kramer, S., Haertel, E., Muzumdar, S., Wagner, J., Tanner, Y., Böhm, F., Smola, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0614 · Cited by 47
Laminin 5 Regulates Polycystic Kidney Cell Proliferation and Cyst Formation
Joly, D. A., Bérissi, S., Bertrand, A., Strehl, L., Patey, N., & Knebelmann, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606151200 · Cited by 48
A Transposon-Based Analysis of Gene Mutations Related to Skin Cancer Development
Quintana, R. M., Dupuy, A. J., Bravo, A., Casanova, M. L., Alameda, J. P., Page, A., Sánchez-Viera, M., Ramírez, Á., & Navarro, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.245 · Cited by 53
“Although activation of RAS is common in human SCC (Dajee et al., 2003), and mutations in genes such as XPC (de Feraudy et al.”
BackgroundLi, Y., Liu, J., Yuan, C., Cui, B., Zou, X., & Qiao, Y. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800518 · Cited by 49
An in vitro three‐dimensional model of primary human cutaneous squamous cell carcinoma
Commandeur, S., de Gruijl, F. R., Willemze, R., Tensen, C. P., & Ghalbzouri, A. E. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00856.x · Cited by 54
Das, I., Acharya, A., Berry, D. L., Sen, S., Williams, E. M., Permaul, E., Sengupta, A., Bhattacharya, S., & Saha, T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511006283 · Cited by 58
Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia
Zhang, J. Y., Adams, A. E., Ridky, T. W., Tao, S., & Khavari, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4017 · Cited by 51
“Oncogenic Ras alone induces growth arrest in primary human keratinocytes in the G1 phase of the cell cycle ( 19 , 31).”
BackgroundInfluentialSelf-citationJewett, A., Cacalano, N. A., Teruel, A., Romero‐Reyes, M., Rashedi, M., Wang, M., & Nakamura, H. K. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0093-7 · Cited by 46
Nemo‐like kinase suppresses a wide range of transcription factors, including nuclear factor‐kB
Yasuda, J., Yokoo, H., Yamada, T., Kitabayashi, I., Sekiya, T., & Ichikawa, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03170.x · Cited by 46
Wang, X., Li, N., Li, H., Liu, B., Qiu, J., Chen, T., & Cao, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0879 · Cited by 48
Dutta, U., & Shaw, L. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2125 · Cited by 45
“Finally, a role for the a6h4 integrin in tumor initiation has been shown in a Ras-induced squamous cell carcinoma mouse model ( 22 ).”
BackgroundRegulation of the let-7a-3 Promoter by NF-κB
Wang, D. J., Legesse-Miller, A., Johnson, E. L., & Coller, H. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031240 · Cited by 45
CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK/AP1 Signaling at Multiple Levels
de Marval, P. L. M., Lutfeali, S., Jin, J. Y., Leshin, B., Selim, M. A., & Zhang, J. Y. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0360 · Cited by 45
Self-citationTranscriptional profiling of epidermal differentiation
Radoja, N., Gazel, A., Banno, T., Yano, S., & Blumenberg, M. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00031.2006 · Cited by 50
Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis
Li, X., & Hu, Y. (2021) · Cancers · doi:10.3390/cancers13061411 · Cited by 47
Hussein, N., Casse, H., Fontanière, S., Morera, A.-M., Asensio, M., Bakeli, S., Lu, J. L., Coste, I., di Clemente, N., Bertolino, P., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.038 · Cited by 47
NF‐κB Signaling: Pros and Cons of Altering NF‐κB as a Therapeutic Approach
Egan, L. J., & Törüner, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.009 · Cited by 54
Intrinsic Signaling Functions of the β4 Integrin Intracellular Domain
Merdek, K. D., Yang, X., Taglienti, C. A., Shaw, L. M., & Mercurio, A. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703156200 · Cited by 49
Erratum: Ras and Raf pathways in epidermis development and carcinogenesis
Kern, F., Niault, T., & Baccarini, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.108 · Cited by 44
Focal adhesion complex proteins in epidermis and squamous cell carcinoma
Duperret, E. K., & Ridky, T. W. (2013) · Cell Cycle · doi:10.4161/cc.26385 · Cited by 44
Roles of Integrin α6β4 Glycosylation in Cancer
Kariya, Y., Kariya, Y., & Gu, J. (2017) · Cancers · doi:10.3390/cancers9070079 · Cited by 43
“In a mouse model of active H-Ras and IκBα-driven human cutaneous SCC, integrin β4-negative keratinocytes (derived from JEB-PA patients with null ITGB4 gene mutations) failed tumor formation but reintroduction of integrin β4 gene into the cells restored it [27], suggesting that integrin β4 plays an essential role in hu…”
Backgroundβ4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3– N -Glycan Complex
Kariya, Y., Oyama, M., Hashimoto, Y., Gu, J., & Kariya, Y. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0365 · Cited by 43
Hsu, Y., Lee, T., Lin, S., Hsu, S., Juan, S., Hsu, Y.-H., Zhong, W., & Lee, W. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20274 · Cited by 45
“transformation by influencing the cell-cycle machinery in numerous types of cancer [12,18].”
BackgroundPlasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer
Kelly‐Spratt, K. S., Pitteri, S. J., Gurley, K. E., Liggitt, D., Chin, A. P., Kennedy, J. J., Wong, C., Zhang, Q. H., Buson, T. B., Wang, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019721 · Cited by 45
“coli enhanced peritoneal inflammation in a rat model [52].”
BackgroundThyroid Hormones and Gamma Interferon Specifically Increase K15 Keratin Gene Transcription
Radoja, N., Stojadinović, O., Waseem, A., Tomic‐Canic, M., Milisavljevic, V., Teebor, S., & Blumenberg, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3168-3179.2004 · Cited by 42
“NF-B, an activation-associated transcription factor, has antiproliferative effects in the skin ( 12 , 23, 46, 50), while STAT-1 is activated by gamma interferon (IFN-) and induces transcription of keratin K17 and other genes (21, 37, 48).”
BackgroundHintermann, E., Yang, N., O'Sullivan, D., Higgins, J. M. G., & Quaranta, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406301200 · Cited by 41
c-Jun Promotes whereas JunB Inhibits Epidermal Neoplasia
Jin, J. Y., Ke, H., Hall, R. P., & Zhang, J. Y. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.1 · Cited by 41
“However, a single genetic change is usually not sufficient to induce tumor growth, which is exemplified by the fact that oncogenic Ras induces epidermal cell senescence (Dajee et al., 2003).”
BackgroundMethodInfluentialSelf-citationGapuzan, M.-E. R., Schmah, O., Pollock, A. D., Hoffmann, A., & Gilmore, T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208809 · Cited by 47
“There is emerging evidence that the absence of RelA can sometimes contribute to oncogenesis, at least in basal cell carcinomas and possibly colon cancer (van Hogerlinden et al., 1999; Deng et al., 2002; Dajee et al., 2003; Zhang et al., 2004).”
BackgroundInvolvement of Rel/NF-κB transcription factors in senescence
Gosselin, K., & Abbadie, C. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.007 · Cited by 48
Molecular Biology of Basal and Squamous Cell Carcinomas
Emmert, S., Schön, M. P., & Haenssle, H. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0437-2_13 · Cited by 47
Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy
Zhou, B., Rao, L., Peng, Y., Wang, Y., Li, Y., Gao, L., Chen, Y., Xue, H., Song, Y., Liao, M., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-47 · Cited by 42
“However, the proposal that NF-κB leads to the onset of cancer has been changed by the evidence that, for skin cancer, NF-κB activation has been postulated as a safeguard against cancer [27,28].”
BackgroundTNF‐α stimulates Akt by a distinct aPKC‐dependent pathway in premalignant keratinocytes
Faurschou, A., & Gniadecki, R. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00740.x · Cited by 40
CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma
Belkin, D. A., Mitsui, H., Wang, C. Q. F., Gonzalez, J., Zhang, S., Shah, K. R., Coats, I., Suárez‐Fariñas, M., Krueger, J. G., Felsen, D., et al. (2012) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.1609 · Cited by 40
Bohgaki, M., Tsukiyama, T., Nakajima, A., Maruyama, S., Watanabe, M., Koike, T., & Hatakeyama, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.09.006 · Cited by 40
van Hogerlinden, M., Rozell, B. L., Toftgård, R., & Sundberg, J. P. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22706.x · Cited by 46
Adipose tissue macrophages: the inflammatory link between obesity and cancer?
Wagner, M., Steinskog, E. S. S., & Wiig, H. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.991311 · Cited by 41
Makino, S., Mitsutake, N., Nakashima, M., Saenko, V., Ohtsuru, A., Umezawa, K., Tanaka, K., Hirano, A., & Yamashita, S. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.03.003 · Cited by 39
“It has been reported that NF-κB activation is required for normal differentiation of keratinocytes [31], and inhibition of the NF-κB pathway in murine epidermis resulted in hyperproliferation of keratinocytes and spontaneous development of squamous cell carcinomas [32-34].”
BackgroundA comparative study of UV-induced cell signalling pathways in human keratinocyte-derived cell lines
Muthusamy, V., & Piva, T. J. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1412-z · Cited by 39
Gao, K., Dai, D. L., Martinka, M., & Li, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4402 · Cited by 39
“In human keratinocytes, overexpression of RelA caused cell growth arrest (23).”
BackgroundYang, C., Atkinson, S. P., Vilella, F., Lloret, M., Armstrong, L., Mann, D. A., & Lako, M. (2010) · Stem Cells · doi:10.1002/stem.528 · Cited by 43
Genetic ablation of the alpha 6‐integrin subunit in Tie1Cre mice enhances tumour angiogenesis
Germain, M., Arcangelis, A. D., Robinson, S. D., Baker, M., Tavora, B., D’Amico, G., Silva, R., Kostourou, V., Reynolds, L. E., Watson, A., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2654 · Cited by 38
Stratis, A., Pasparakis, M., Markur, D., Knaup, R., Pofahl, R., METZGER, D., Chambon, P., Krieg, T. M., & Haase, I. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700092 · Cited by 38
Oncogenic transformation of human cells: shortcomings of rodent model systems
Akagi, T. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.001 · Cited by 42
Peterson, T. A., Park, D., & Kann, M. G. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s3-s5 · Cited by 40
“This domain position corresponds to position 12 of both the human HRAS and KRAS genes, from which many mutations have been implicated in diseases such as Costello syndrome [43-46] and Congenital myopathy [47,48] and have also been found to be mutated frequently in somatic tumor samples from patients with follicular th…”
BackgroundUnderstanding the Pathogenesis of Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma
South, A. P., & O’Toole, E. A. (2009) · Dermatologic Clinics · doi:10.1016/j.det.2009.10.023 · Cited by 37
Moilanen, J. M., Löffek, S., Kokkonen, N., Salo, S., Väyrynen, J. P., Hurskainen, T. L., Manninen, A., Riihilä, P., Heljäsvaara, R., Franzke, C.-W., et al. (2017) · Scientific Reports · doi:10.1038/srep45057 · Cited by 43
Advances in research on the interaction between inflammation and cancer
Song, X., Wang, Y., Zhang, A., & Liu, B. (2019) · Journal of International Medical Research · doi:10.1177/0300060519895347 · Cited by 43
Riemann, K., Becker, L., Struwe, H., Nückel, H., Dührsen, U., Alakus, H., Winde, G., Neuhäuser, M., Rubben, H., Schmitz, K. J., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230414.74726.f6 · Cited by 37
The Black Box Illuminated: Signals and Signaling
Mascia, F., Denning, M. F., Kopan, R., & Yuspa, S. H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.406 · Cited by 38
“…and thus promotes cancer development in most cell types, however the NF-κB upstream activating kinase IKKα promotes keratinocyte differentiation, and blockade of NF-κB activation with a dominant/negative IκB is a potent oncogene in human keratinocytes (Dajee et al., 2003; Hu et al., 2001).”
BackgroundUVB activation of NF-κB in normal human keratinocytes occurs via a unique mechanism
Lewis, D. A., & Spandau, D. F. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-006-0729-2 · Cited by 43
Li, R., Ochs, M. F., Ahn, S. M., Hennessey, P., Tan, M., Soudry, E., Gaykalova, D. A., Uemura, M., Brait, M., Shao, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091263 · Cited by 36
“The LAMA3A isoform is a subunit of laminin 332, which is highly expressed in squamous cell carcinomas, and may be associated with reduced patient survival as well as increased tumor invasiveness [33,34].”
BackgroundActivation of p73 and induction of Noxa by DNA damage requires NF-kappa B
Martín, Á. G., Trama, J. P., Crighton, D., Ryan, K. M., & Fearnhead, H. O. (2009) · Aging · doi:10.18632/aging.100026 · Cited by 40
Mutant collagen COL11A1 enhances cancerous invasion
Lee, C. S., Siprashvili, Z., Mah, A., Bencomo, T., Elcavage, L. E., Che, Y., Shenoy, R. M., Aasi, S. Z., & Khavari, P. A. (2021) · Oncogene · doi:10.1038/s41388-021-02013-y · Cited by 41
Self-citation
Metadata
- Authors
- Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., & Khavari, P. A.
- Affiliations
- VA Palo Alto Health Care System (US)
- Corresponding author
- Khavari, Paul A.
- ORCID
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6923
- Pages
- 639-643
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986301169
- Cited by
- 535
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 13 · 2017: 7 · 2016: 20 · 2015: 21 · 2014: 22 · 2013: 25 · 2012: 23
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, oncogenic Ras, IκBα, cell cycle arrest, laminin-5, alpha6beta4 integrin, carcinogenesis, skin cancer
- MeSH terms
- NF-KappaB Inhibitor alpha, Kalinin, Animals, Cell Division, Epidermis, Humans, Mice, Nude, Neoplasm Invasiveness, Neoplasms, Genes, ras, Transduction, Genetic, Keratinocytes, Oncogene Protein p21(ras), Cell Adhesion Molecules, NF-kappa B, Mice, SCID, Telomere, Apoptosis, Cyclin-Dependent Kinases, I-kappa B Proteins, Integrin alpha6beta4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.